Healthcare Holding Schweiz AG enhances its portfolio by acquiring a stake in QUNIQUE GmbH, a leading consulting firm in the medical technology sector, aimed at improving regulatory compliance services.

Target Information

Healthcare Holding Schweiz AG, a premier provider of medical technology services and distribution solutions in Switzerland, has expanded its portfolio by acquiring a stake in QUNIQUE GmbH. This strategic move strengthens Healthcare Holding's expertise in regulatory affairs and quality management. QUNIQUE, based in Wohlen, is recognized as one of the leading consulting firms in the medical technology sector, holding an ISO 13485 certification. The firm aids manufacturers, importers, distributors, hospitals, and suppliers to ensure compliance with regulatory and quality standards across Switzerland and the European Union. Additionally, QUNIQUE serves as a CH-REP and CH-Importer for many prominent international MedTech manufacturers, and it extends its services through its German subsidiary, acting as EU-REP and EU-Importer.

Fabio Fagagnini, CEO of Healthcare Holding Schweiz AG, remarked, “QUNIQUE is a dynamic and rapidly growing consultancy that perfectly complements our group’s offerings as a medical technology distributor. Its experienced specialists will now also provide support to our suppliers, while QUNIQUE maintains its independent market presence, offering its existing and future clients expert guidance—enhanced by our collective knowledge and experience.”

Industry Overview

Switzerland boasts a robust medical technology industry that is recognized globally for its innovation and quality standards. The Swiss MedTech sector is characterized by a high density of leading companies, many of which are

View Source

Similar Deals

Galenica Labor Team Group

2025

Other Pharmaceuticals (NEC) Switzerland
Galderma Galderma shares

2025

Other Pharmaceuticals (NEC) Switzerland
Galenica Labor Team Gruppe

2025

Other Pharmaceuticals (NEC) Switzerland
Addex Therapeutics Stalicla

2025

Other Proprietary & Advanced Pharmaceuticals Switzerland
Relief Therapeutics Holding SA NeuroX Group SA

2025

Other Biopharmaceuticals Switzerland
Novartis MorphoSys AG

2024

Other Proprietary & Advanced Pharmaceuticals Switzerland

Healthcare Holding Schweiz AG

invested in

QUNIQUE GmbH

in 2025

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert